Matheis Dennis Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$168.50
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Matheis Dennis

According to the SEC Form 4 filings, Matheis Dennis, being in a position of

  1. director at DarioHealth Corp.,
    оver the last 12 months, has bought 14430 shares for $100,000, and sold 0 shares,
    over all time since 2020-08-18, has bought 29480 shares for $100,168, and sold 0 shares.

Biography of Matheis Dennis

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $345,2692100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-07-23PurchaseDarioHealth Corp.
DRIO
director
14,430
0.1831%
$6.93$100,000-8.37%
2026-05-20PurchaseLucid Diagnostics Inc.
LUCD
director
245,000
0.2397%
$1.00$245,270-3.89%
2025-08-20PurchaseLucid Diagnostics Inc.
LUCD
director
100,000
0.0911%
$1.02$101,840+5.83%
2025-05-22PurchaseLucid Diagnostics Inc.
LUCD
director
33,218
0.0304%
$1.32$43,795-14.29%
2025-05-21PurchaseLucid Diagnostics Inc.
LUCD
director
129,684
0.1192%
$1.32$171,520-14.29%
2025-05-20PurchaseLucid Diagnostics Inc.
LUCD
director
187,098
0.1723%
$1.29$242,292-11.54%
2023-05-04PurchaseDarioHealth Corp.
DRIO
director
50
–
$3.37$169-39.45%
2020-08-18PurchaseDarioHealth Corp.
DRIO
director
15,000
–
$0$0-8.24%
Total: 8
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.